Ignite Creation Date:
2024-05-05 @ 5:04 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00372333
Status:
COMPLETED
Last Update Posted:
2009-03-20
First Post:
2006-09-04
Brief Title:
IDEA-033 Open Label Study
Sponsor:
IDEA AG
Organization:
IDEA AG
Study Overview
Official Title:
A Multiple-Dose Open-Label Safety Compliance and Usage Evaluation Study of Epicutaneously Applied IDEA-033 in Joint Musculoskeletal Pain or Soft Tissue Inflammation
Status:
COMPLETED
Status Verified Date:
2009-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The main aim of the study is to evaluate safety efficacy compliance and usage of epicutaneously applied IDEA-033 in joint musculoskeletal pain or soft tissue inflammation
Detailed Description:
Multi-centre one arm multiple dose open-label at home usage study Adult volunteers experiencing joint pain musculoskeletal pain stiffness or soft tissue inflammation will be screened for study participation
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None